i2O Therapeutics
Saratoga, US · Founded 2019 · Delaware corporation · 6 employees on LinkedIn · 3 known investors
Biotechnology company developing safe and effective oral formulations of therapies traditionally limited to injections using ionic liquid technology
Founders & leadership
i2O Therapeutics was founded in 2019 by Mitragotri Mitragotri and Ravi Srinivasan.
MM
Mitragotri MitragotriCo-founder
RS
Ravi SrinivasanCo-founder
Investors · 3
Reported raises · per SEC filings
Form D private placements$43.9M disclosed across 6 rounds · 2019–2023
▶$3.5MraisedOct 2023 · 7 investors · BiotechnologyRule 506(b)
▶$3.5MraisedOct 2023 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Christopher GagliardiDirector
- Kurt GravesExecutive Officer, Director
- Anthony AiudiDirector
- Offering amount
- $4M
- Amount sold
- $3.5M
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$33.5MraisedOct 2022 · 17 investors · BiotechnologyRule 506(b)
▶$33.5MraisedOct 2022 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ravi SrinivasanExecutive Officer, Director
- Christopher GagliardiDirector
- Kurt GravesDirector
- Samir MitragotriExecutive Officer, Director
- Anthony AiudiDirector
- Offering amount
- $42M
- Amount sold
- $33.5M
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$2.3MraisedJan 2022 · 7 investors · BiotechnologyRule 506(b)
▶$2.3MraisedJan 2022 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Samir MitragotriExecutive Officer, Director
- Kurt GravesDirector
- Ravi SrinivasanExecutive Officer, Director
- Katie ElliasDirector
- Christopher GagliardiDirector
- Offering amount
- $3M
- Amount sold
- $2.3M
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$600KraisedDec 2020 · 2 investors · BiotechnologyRule 506(b)
▶$600KraisedDec 2020 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Samir MitragotriExecutive Officer, Director
- Christopher GagliardiDirector
- Ravi SrinivasanExecutive Officer, Director
- Katie ElliasDirector
- Offering amount
- $600K
- Amount sold
- $600K
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$3.2MraisedMar 2020 · 2 investors · BiotechnologyRule 506(b)
▶$3.2MraisedMar 2020 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Samir MitragotriExecutive Officer, Director
- Katie ElliasDirector
- Christopher GagliardiDirector
- Ravi SrinivasanExecutive Officer, Director
- Offering amount
- $3.2M
- Amount sold
- $3.2M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$800KraisedJul 2019 · 2 investors · BiotechnologyRule 506(b)
▶$800KraisedJul 2019 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mitragotri MitragotriExecutive Officer, Director
- Ravi SrinivasanExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $800K
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does i2O Therapeutics do?
- Biotechnology company developing safe and effective oral formulations of therapies traditionally limited to injections using ionic liquid technology
- Who founded i2O Therapeutics?
- i2O Therapeutics was founded by Mitragotri Mitragotri, Ravi Srinivasan in 2019.
- Who are i2O Therapeutics's investors?
- i2O Therapeutics's investors include 7G BioVentures, Sanofi Ventures, JDRF T1D Fund.
- How much funding has i2O Therapeutics raised?
- i2O Therapeutics has disclosed $43.9M raised across 6 rounds.
- Where is i2O Therapeutics headquartered?
- i2O Therapeutics is headquartered in Saratoga, US.